Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FTC Continues Effort To Eliminate Orange Book’s Improper Patent Listings
Jun 10 2025
•
By
Urtė Fultinavičiūtė
The FTC continues to send warning letters about potentially improper patent listings in the Orange Book.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Patents
More from Legal & IP